| Gene symbol | KLRK1 | Synonyms | CD314, D12S2489E, KLR, NKG2-D, NKG2D | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | killer cell lectin like receptor K1 | ||||
| GTO ID | GTC1797 |
| Trial ID | NCT03310008 |
| Disease | Colon Cancer |
| Altered gene | NKG2D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | NKG2D CAR-T cells |
| Co-treatment | FOLFOX |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases |
| Year | 2017 |
| Country | Belgium |
| Company sponsor | Celyad Oncology SA |
| Other ID(s) | CYAD-N2T-003 |
| Cohort 1 | |||||||||
|
|||||||||